Enjoying watching my son do Pedal the Cause. @pedalthecause

Congratulations Dr. Hogg and team @SciImmunology: #dendritic cells can matter in #PancreaticCancer, patients. See it at https://t.co/H1qM3Sx9Vy Big thanks to Swim Across America @SAA_Inc St. Louis and Pedal the Cause @pedalthecause for supporting this research and trial.

A dual therapy that targets conventional #dendritic cells can boost T cell-mediated antitumor immunity in #PancreaticCancer, according to a new study involving patient samples and mice. @DeNardoLabWUSM Learn more in Science #Immunology: https://t.co/xHy49LnS8k

NIH personnel, I want you to know we as scientist appreciate all you do to support our research.

📢New human fetal pancreatic organoid model generates all three key cell types of the pancreas. New paper in @CellCellPress by @AmandaARolf , @HansClevers and collaborators. See the article here: https://t.co/xcuc8drybh

The December issue of @CD_AACR is now online! The cover features work by @olaf_klingbeil, @ChrisVakoc, and colleagues showing MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer - read that, the year-in-review collection, & more:

New #OpenAccess from @CCR_AACR Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic #PancreaticCancer https://t.co/ayCTMMdZXQ Median OS - 13.2 months 1-year survival rate -

The @ChampalimaudF #PancreaticCancer symposium kicks off with an opening lecture by @EileenMOReilly @MSKCancerCenter on the oncological landscape of available & in development Rx against PDAC. A nod to KRAS targeted therapies, including freshly presented #ENA2024 data.

Dr. Lisa Coussens (@coussens_lisa) is recognized for her paradigm-shifting mechanistic studies on inflammation and cancer that identified B cell and myeloid cell significance in fostering solid tumor progression and hindering therapeutic responses: https://t.co/qFZSKnkEKn

Congratulations Dr. Liu @SitemanCenter and collaborators @LabBeatty and K.Bryant on their featured article in @ScienceTM . And HUDGE THANKS to @PanCAN for bringing this team together and funding the trial that came out of the science with @verastemoncology.

Congratulations Dr. Liu and collaborators @LabBeatty and K.Bryant on their featured article in @ScienceTM. And HUDGE THANKS to @PanCAN for bringing this team together and funding the trial that came out of the science with @verastemoncology

Now online in @CD_AACR: back-to-back papers from the labs of @sastewartlab and @DeNardoLabWUSM on immunosuppression by senescent CAFs in breast and pancreatic cancers https://t.co/fM7ac7UHNp https://t.co/mtmOoZfUiN @jennifer_jiayu @JadBelle #DevashishSen @WUSTLmed @SitemanCenter

Turns our MyCAFs become Senescent (SenCAFs) and can drive both breast and pancreas cancer progression through immune modulation. See just now online at Cancer Discovery https://t.co/fpbezZOKfe https://t.co/9xsnydtLCK

Congratulations to Bell and Yi on back to back @CD_AACR papers. Go @sastewartlab and @SitemanCenter https://t.co/9xsnydtLCK

Portrait unveiling at the conclusion of the John F DiPersio Immunotherapy Symposium @WashUOnc @SitemanCenter @WUDeptMedicine @WUSTLmed @BarnesJewish @WUSTLdbbs @WashUDPS #bmtsm #celltherapy #cartcells #leusm #lymsm #mmsm #mdssm

We are thrilled to announce that these trainees will be joining our team!! Congrats and welcome to #radonc! #MatchRadonc #SWRO #wewhocurie #WashUMed #Match2024

Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer https://t.co/RGpPEltsHl

Congratulations @megeblad and team!

Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment https://t.co/y3wvCxKTiK

@WUSTLmed radiation oncologist Julie Schwarz, MD, PhD, (@JulieSchwarz14) of Siteman has been named a William H. Danforth Washington University Physician Scholar in part for her research to develop new treatments for gynecologic cancers. https://t.co/cYG7VVa3ct